Onconic Therapeutics Inc.

₩11,680As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:476060Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 33.51%
Biotechnology
Beta (5Y) —
PE TTM 22.10
TSR TTM (31.86%)
Mkt cap ₩530.4B
ROIC 14.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩11,290
(3.34%)
(30.63%)
Hold 9|5|10|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
136.21
145.55
155.65
153.31
13.02%
19.14%
33.51%
18.53%
Revenue₩B
48.38
47.45
50.02
51.66
14.46%
9.45%
9.82%
10.59%
Peers (US$391.0M)
Cap (US$)
PE
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.574
0.011
—
EBIT/Intx
1.050
0.665
0.513
Own earn%
28.20
(142.48)
(169.09)
Sh yield%
29.71
63.32
61.80
Owners
Insiders/Inst%
11.95
37.71
Short interest%
2.06
SBC / revenue%
3.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
19–29
$1 testx
—
Incr. ROIC%
18